Skip to Main Content
Back to News

Datavault AI Stock (DVLT) Opinions on Wellgistics Health Partnership

None

Strategic Partnership Sparks Buzz: Recent posts on X are abuzz with news of Datavault AI's partnership with Wellgistics Health, focusing on blockchain-enabled prescription drug tracking. Many are intrigued by the potential for this collaboration to transform healthcare logistics. The announcement has driven significant attention to the stock, with some noting a sharp uptick in trading activity.

Investment and Expansion News: Discussions also center on a reported $150 million investment and an expanded IBM partnership, fueling excitement about the company's growth prospects. Some users highlight the stock's price movement and speculate on long-term potential from strategic moves like the Swiss exchange deal. There's a sense of anticipation around how these developments might impact future performance.

Concerns Amid Optimism: Despite the enthusiasm, a few voices on X express caution over ongoing profitability challenges and market volatility. Posts mention recent dips in stock price, urging careful monitoring of financial health. The mix of optimism and concern keeps the conversation dynamic and engaging.

Note: This discussion summary was generated from an AI condensation of post data.

Datavault AI Insider Trading Activity

DVLT Insider Trades

Datavault AI insiders have traded $DVLT stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $DVLT stock by insiders over the last 6 months:

  • BRETT MOYER (See Remarks) sold 130,754 shares for an estimated $52,301
  • NATHANIEL T BRADLEY (Chief Executive Officer) has made 0 purchases and 2 sales selling 34,253 shares for an estimated $13,701.
  • STANLEY MBUGUA (See Remarks) sold 33,920 shares for an estimated $13,568

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Datavault AI Hedge Fund Activity

We have seen 3 institutional investors add shares of Datavault AI stock to their portfolio, and 0 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Datavault AI Analyst Ratings

Wall Street analysts have issued reports on $DVLT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Maxim Group issued a "Buy" rating on 06/12/2025

To track analyst ratings and price targets for Datavault AI, check out Quiver Quantitative's $DVLT forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles